Last reviewed · How we verify
NCT04823013
Comparison of High Power Pain Threshold Ultrasound and Ischemic Compression Techniques for Treatment of Trigger Points
NA trial testing high power pain threshold ultrasound which the dose was kept constant in Trigger Point Pain, Myofascial in 153 participants. Completed in 1 April 2018.
1 April 2018
Quick facts
| Lead sponsor | Gazi University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 153 |
| Start date | 1 October 2017 |
| Primary completion | 1 April 2018 |
| Estimated completion | 1 April 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- high power pain threshold ultrasound which the dose was kept constant
- high power pain threshold ultrasound which the dose reduced to one half
- ischemic compression
Conditions studied
- Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →
Sponsor
Gazi University
Who can join
Adults 18 to 50, any sex, with Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to compare the efficacy of ischemic compression and two different application methods of high power pain threshold ultrasound techniques on latent trigger point treatment. Asymptomatic subjects divided into three groups. First group took high power pain threshold ultrasound in which the intensity is kept constant at the pain level; second group took high power pain threshold ultrasound which the intensity is kept constant at half the pain level and third group took ischemic compression. All participants were asked to complete the questionnaires, which assessed pain, psychological factors and disability before treatment, after 1 week and 1 month follow-up. After each participants completed the questionnaire, the physical therapist evaluated the MTrPs. MTrPs assessment was performed before treatment, immediately after treatment, after 1 week and 1 month follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04823013
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trigger Point Pain, Myofascial
Currently open trials in the same condition.
- NCT07138807 — Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses · NA · recruiting
- NCT06986707 — Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points · NA · recruiting
- NCT06986317 — Effectiveness of Positional Release Techniques and Graston Technique In Trigger Point · NA · recruiting
- NCT06664359 — Safe Zone in Trigger Point Injection · recruiting
- NCT06316583 — Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints · NA · recruiting
Other Gazi University trials
Trials by the same sponsor.
- NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
- NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
- NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
- NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
- NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04823013 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gazi University
- Last refreshed: 30 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04823013.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing